GlassScriptPhysician profile
Monica A Brown
NPI 1548596976
$2,061.25
in general payments reported to CMS, 2019-2025
20 companies · $328 in 2025
The $328 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $28.78 · 2022: $99.46 · 2023: $539 · 2024: $1,066 · 2025: $328.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,933.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,933.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $449.28 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $358.83 | 2023-2025 | Airsupra, Breztri, Farxiga |
| Novo Nordisk INC | $285.68 | 2022-2024 | Rybelsus, Ozempic, Wegovy |
| Lilly USA, LLC | $253.93 | 2022-2025 | Mounjaro, Jardiance, Zepbound |
| Pfizer INC. | $152.20 | 2021-2024 | |
| Glaxosmithkline, LLC. | $65.19 | 2024-2025 | Trelegy Ellipta, Arexvy |
| Otsuka America Pharmaceutical, INC. | $58.03 | 2023 | Rexulti, Nuedexta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $56.08 | 2023-2024 | Synjardy, Jardiance, Tradjenta |
| Abbott Laboratories | $50.85 | 2022 | |
| Exact Sciences Corporation | $47.55 | 2023 | Cologuard Collection Kit |
| Astellas Pharma US INC | $46.04 | 2025 | Veozah |
| Daiichi Sankyo INC. | $41.96 | 2024-2025 | Injectafer |
| Amgen INC. | $34.48 | 2023-2024 | Otezla, Repatha |
| Bayer Healthcare Pharmaceuticals INC. | $31.17 | 2023 | |
| Eisai INC. | $26.25 | 2025 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $24.09 | 2025 | Dexcom G6 Transmitter |
| Phathom Pharmaceuticals, INC. | $22.43 | 2025 | Voquezna |
| Sanofi Pasteur INC. | $21.61 | 2023 | |
| Merck Sharp & Dohme LLC | $20.57 | 2025 | Capvaxive, Gardasil 9 |
| Tempus Ai, INC | $15.03 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Monica Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.